[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "HTML PRIDE EM ROW CS SHALL NCE LIMITED HEREIN BE instrument cleavage agent details PRIDE:0000659 DOID OR MOD PS DJ fractionation method SP FITNESS FDR file your SILAC OPTIONAL COLUMN RFC CL pooled sample EFO DTT DIA EW MUST DISCLAIMS WARRANTY CN README COULD data file URI organism URL SN sex label VK biological replicate BTO CLO INFORMATION disease stage XML SDRF fraction identifier SHOULD NT DDA replicate NOT biosample accession number TMT RECOMMENDED UBERON ... PATO developmental stage HF PO LI CF PEPTIDESEQ WILL IAA MAY WARRANTIES alkylation reagent TO characteristics FOR MC PTM HANCESTRO ANY ZFA HUPO ALL MIAME THE BRENDA TIP organism part spiked compound AS II LC ID SH cell type depletion MINOR MONDO PP VCF IMPLIED THAT HCD STANDARDS MS MT PRM source name disease IDF NOTE CPTAC PSI PMCID PMID NCBI REQUIRED MAJOR TAB CT source name_ and _assay name INFRINGE RECOMMEND PURPOSE PROTEOMICS IMPORTANT technical replicate JA CV SRM CID QY REQUIRES ENVO age RAW ancestry category ISA individual RIGHTS INITIATIVE USE PATCH IS mass PARTICULAR AC MHC MS:1001251 proteomics data acquisition method MAGE CELL EBI sample reduction reagent XL dissociation method INCLUDING OF MERCHANTABILITY EXPRESS BUT collision energy TA SWATH exclamation BMC III"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "HTML PRIDE EM ROW CS SHALL NCE LIMITED HEREIN BE instrument cleavage agent details PRIDE:0000659 DOID OR MOD PS DJ fractionation method SP FITNESS FDR SILAC OPTIONAL COLUMN RFC CL pooled sample EFO DTT DIA EW MUST DISCLAIMS WARRANTY CN README COULD data file URI organism URL SN sex label VK biological replicate BTO CLO INFORMATION disease stage SDRF fraction identifier SHOULD NT DDA NOT biosample accession number TMT RECOMMENDED UBERON ... PATO HF PO LI CF PEPTIDESEQ WILL IAA MAY WARRANTIES alkylation reagent TO FOR MC PTM HANCESTRO ANY ZFA HUPO ALL MIAME THE BRENDA organism part spiked compound AS II LC SH cell type depletion MINOR MONDO PP VCF IMPLIED THAT HCD STANDARDS MS MT PRM disease IDF CPTAC PSI PMCID PMID NCBI REQUIRED MAJOR TAB CT INFRINGE RECOMMEND PURPOSE PROTEOMICS technical replicate JA CV SRM CID QY REQUIRES ENVO age RAW ancestry category ISA individual RIGHTS INITIATIVE USE PATCH IS mass PARTICULAR AC MHC MS:1001251 proteomics data acquisition method MAGE CELL EBI reduction reagent XL dissociation method INCLUDING OF MERCHANTABILITY EXPRESS BUT collision energy TA SWATH BMC III"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000623 disease model CL:0000540 UBERON:0002107 CSF DOID MONDO:0008383 CL:0000913 MONDO:0005105 UBERON:0000955 MONDO:0100096 CL EFO MUST organism URL sex PATO:0000384 biological replicate CL:0000624 compound MONDO:0005180 CL:0000233 SDRF MONDO:0005575 SHOULD PDX UBERON:0002048 UBERON:0001155 UBERON PATO developmental stage PO CL:0000788 CL:0000813 MONDO:0004989 MAY UBERON:0000948 MONDO:0004946 CL:0000576 synthetic peptide DSS PATO:0000383 PTM MONDO:0005138 HANCESTRO MONDO:0005301 NSG MONDO:0004975 CL:0000182 CL:0000232 ALL TIP organism part CL:0000898 ID MONDO:0005148 cell type depletion MONDO UBERON:0000178 UBERON:0001977 source name disease CML NOTE PATO:0001340 UBERON:0002097 NCBI UBERON:0000310 UBERON:0001969 APP CL:0000451 IMPORTANT CL:0000787 UBERON:0001359 NK COVID age ancestry category enrichment process UBERON:0001088 individual CL:0000057 CL:0000815 PATO:0000461 CL:0000625 UBERON:0002113 CL:0000066 CL:0000236 CL:0000084 CL:0000235 exclamation lib xenograft"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000623 disease model CL:0000540 UBERON:0002107 CSF DOID MONDO:0008383 CL:0000913 MONDO:0005105 UBERON:0000955 MONDO:0100096 CL EFO MUST organism URL sex PATO:0000384 biological replicate CL:0000624 compound MONDO:0005180 CL:0000233 SDRF MONDO:0005575 SHOULD PDX UBERON:0002048 UBERON:0001155 UBERON PATO developmental stage PO CL:0000788 CL:0000813 MONDO:0004989 MAY UBERON:0000948 MONDO:0004946 CL:0000576 synthetic peptide DSS PATO:0000383 PTM MONDO:0005138 HANCESTRO MONDO:0005301 NSG MONDO:0004975 CL:0000182 CL:0000232 ALL organism part CL:0000898 ID MONDO:0005148 cell type depletion MONDO UBERON:0000178 UBERON:0001977 source name disease CML PATO:0001340 UBERON:0002097 NCBI UBERON:0000310 UBERON:0001969 APP CL:0000451 CL:0000787 UBERON:0001359 NK COVID age ancestry category enrichment process UBERON:0001088 individual CL:0000057 CL:0000815 PATO:0000461 CL:0000625 UBERON:0002113 CL:0000066 CL:0000236 CL:0000084 CL:0000235 xenograft"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "MONDO:0005300 HANCESTRO:0010 NCIT:C65106 dose pregnancy status pre-existing condition NCIT:C53556 CHEBI:6801 MONDO:0002050 NCIT:C28077 NCIT:C71732 EFO height treatment response organism NCIT:C18213 CHEBI:27899 sex HANCESTRO:0005 TNM disease stage NCIT:C27971 NCIT:C27966 compound SDRF AJCC NCIT:C53553 NCIT:C53554 NCIT:C14169 Dukes stage sampling time point GDPR PREFERRED NCIT:C62723 NCIT:C14168 NCI ER NCIT:C15262 NCIT:C28079 HANCESTRO NCIT:C53555 NCIT:C27970 NCIT:C81327 NCIT:C16358 MONDO:0004979 gestational age NCIT:C18058 NCIT:C65108 PD organism part ethnicity BMI II NCIT:C15329 ID MONDO:0005148 HIPAA NCIT:C81328 NCIT:C68804 MONDO MONDO:0005044 CHEBI:28748 breast cancer subtype diet ACE disease secondary condition NOTE CHEBI:41774 HANCESTRO:0006 IV time post treatment NCIT:C28078 NCIT:C15313 NCIT:C15445 Ann Arbor stage MONDO:0011122 menopausal status IMPORTANT HANCESTRO:0009 medication history NCIT:C14167 treatment status NCIT age MONDO:0004995 ancestry category NCIT:C65107 tumor grade alcohol consumption individual UO TNM staging weight NCIT:C14174 treatment NCIT:C4870 NCIT:C28076 body mass index smoking status prior treatment PR NCIT:C18206 exclamation NCIT:C15632 NCIT:C28054 III"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "MONDO:0005300 HANCESTRO:0010 NCIT:C65106 dose pregnancy status pre-existing condition NCIT:C53556 CHEBI:6801 MONDO:0002050 NCIT:C28077 NCIT:C71732 EFO height treatment response organism NCIT:C18213 CHEBI:27899 sex HANCESTRO:0005 TNM disease stage NCIT:C27971 NCIT:C27966 compound SDRF AJCC NCIT:C53553 NCIT:C53554 NCIT:C14169 Dukes stage sampling time point GDPR PREFERRED NCIT:C62723 NCIT:C14168 NCI ER NCIT:C15262 NCIT:C28079 HANCESTRO NCIT:C53555 NCIT:C27970 NCIT:C81327 NCIT:C16358 MONDO:0004979 gestational age NCIT:C18058 NCIT:C65108 PD organism part ethnicity BMI II NCIT:C15329 ID MONDO:0005148 HIPAA NCIT:C81328 NCIT:C68804 MONDO MONDO:0005044 CHEBI:28748 breast cancer subtype diet ACE disease secondary condition CHEBI:41774 HANCESTRO:0006 IV time post treatment NCIT:C28078 NCIT:C15313 NCIT:C15445 Ann Arbor stage MONDO:0011122 menopausal status HANCESTRO:0009 medication history NCIT:C14167 treatment status NCIT age MONDO:0004995 ancestry category NCIT:C65107 tumor grade alcohol consumption individual UO TNM staging weight NCIT:C14174 treatment NCIT:C4870 NCIT:C28076 body mass index smoking status prior treatment PR NCIT:C18206 NCIT:C15632 NCIT:C28054 III"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "technical replicate file uri MS2 analyzer type PRIDE CS MS:1001306 SDRF fraction identifier SHOULD NT MS:1001309 DDA SRM MS1 scan range TIP instrument SCIEX PRIDE:0000663 TMT MGF scan window upper limit RECOMMENDED RAW cleavage agent details UNIMOD:35 LTQ ID FTP ST modification parameters MOD MS:1001303 PP HF SILAC CF MS MT PRM KR UNIMOD:4 MRM scan window lower limit ELISA fragment mass tolerance DIA AC NOTE fraction MUST TS MS:1001251 proteomics data acquisition method precursor mass tolerance sample data file PSI XL TOF proteomexchange accession number MS:1001313 MS:1001917 URI UNIMOD:737 REQUIRED URL UNIMOD MSD UNIMOD:1 TA label UNIMOD:21 exclamation MM RPPA IMPORTANT"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "technical replicate file uri MS2 analyzer type PRIDE CS SDRF fraction identifier SHOULD NT MS:1001309 DDA SRM MS1 scan range instrument SCIEX PRIDE:0000663 TMT MGF scan window upper limit RECOMMENDED RAW cleavage agent details UNIMOD:35 LTQ ID FTP ST modification parameters MOD MS:1001303 PP HF SILAC CF MS MT PRM KR UNIMOD:4 MRM scan window lower limit ELISA fragment mass tolerance DIA AC MUST TS MS:1001251 proteomics data acquisition method precursor mass tolerance data file PSI XL TOF proteomexchange accession number MS:1001313 MS:1001917 URI UNIMOD:737 REQUIRED URL UNIMOD MSD UNIMOD:1 TA label UNIMOD:21 MM RPPA MS:1001306"
  }
]